These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 6512792)
61. The toxicity of D-penicillamine in systemic sclerosis. Steen VD; Blair S; Medsger TA Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530 [TBL] [Abstract][Full Text] [Related]
62. [Basic therapy of rheumatoid arthritis with D-penicillamine. Personal contribution and critical observations]. Gigante D; Teodori S; Crispo M Fortschr Med; 1983 Apr; 101(13):613-8. PubMed ID: 6852728 [No Abstract] [Full Text] [Related]
63. [Retrospective study of the effects of D-penicillamine and pyrithioxin in the treatment of rheumatoid arthritis]. Clerc D; Sallière D; Segond P; Bisson M; Massias P Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):281-7. PubMed ID: 6879095 [TBL] [Abstract][Full Text] [Related]
64. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485 [TBL] [Abstract][Full Text] [Related]
65. [Severe side-effects of treatment with D-penicillamine (author's transl)]. Hennemann HH; Hubertus H; Stocker WG Dtsch Med Wochenschr; 1975 Aug; 100(32):1634-8. PubMed ID: 1172464 [TBL] [Abstract][Full Text] [Related]
66. The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis. Kean WF; Dwosh IL; Anastassiades TP; Ford PM; Kelly HG Arthritis Rheum; 1980 Feb; 23(2):158-64. PubMed ID: 7362666 [TBL] [Abstract][Full Text] [Related]
67. [100 cases of common rheumatoid polyarthritis, treated with D-penicillamin]. Camus JP; Crouzet J; Guillien P; Benichou C; Lievre JA Ann Med Interne (Paris); 1974 Jan; 125(1):9-28. PubMed ID: 4603018 [No Abstract] [Full Text] [Related]
68. [D-penicillamine therapy of chronic polyarthritis]. Günther R; Gabl F; Knapp E Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805 [No Abstract] [Full Text] [Related]
75. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis]. Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994 [No Abstract] [Full Text] [Related]
76. [Current status of D-penicillamine therapy in chronic polyarthritis]. Franke M; Menning H; Ströbel G Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106 [TBL] [Abstract][Full Text] [Related]
77. [Glomerulopathy in rheumatic patients due to penicillamine]. Muller V; Krumhaar I; Schneider W; Ditscherlein G Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094 [TBL] [Abstract][Full Text] [Related]
78. [Blood cytopenias induced by D-penicillamine in rheumatoid arthritis - a report of 51 patients (author's transl)]. Aymard JP; Netter P; Witz F; Colomb JN; Lederlin P; Pourel J; Gaucher A; Herbeuval R Therapie; 1981; 36(3):337-41. PubMed ID: 7292413 [No Abstract] [Full Text] [Related]
79. [The basal therapy of rheumatoid arthritis with d-penicillamine (author's transl)]. Waskönig FW; Meyer W Munch Med Wochenschr; 1973 Nov; 115(45):2047-50. PubMed ID: 4801138 [No Abstract] [Full Text] [Related]
80. [Experiences in the treatment of chronic polyarthritis using D-penicillamine (proceedings)]. Dürrigl T; Pucar I Z Rheumatol; 1976; 35 Suppl 4():suppl 464-9. PubMed ID: 983407 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]